Nabilone for Agitation Blinded Intervention Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Agitation
- Alzheimer Disease
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 55 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04516057
- Collaborators
- Alzheimer's Drug Discovery Foundation
- Weston Brain Institute
- Investigators
- Principal Investigator: Krista L. Lanctôt, PhD Sunnybrook Research Institute Principal Investigator: Nathan Herrmann, MD Sunnybrook Health Sciences Centre Principal Investigator: Giovanni Marotta, MD Sunnybrook Health Sciences Centre